Goldenwell Biotech, Inc.
GWLLOTCConsumer Defensive● Active
$0.52
+$0.00(+0.00%)
Market Cap$51480000
P/E Ratio—
52W High$10
52W Low$0.2
Goldenwell Biotech, Inc.（GWLL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GWLL · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00M | $0.00M | $0.05M | $0.02M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.02M | $0.01M | $0.00M |
| Gross Profit | $0.00M | $0.00M | $0.03M | $0.01M | $0.00M |
| Gross Margin %(computed) | 46.04% | 47.35% | 52.69% | 52.53% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.12M | $0.12M | $1.01M | $0.13M | $0.01M |
| Total Operating Expenses | $0.12M | $0.12M | $1.01M | $0.13M | $0.01M |
| Operating Income | ($0.12M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Operating Margin %(computed) | — | — | — | -740.70% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.13M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.13M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Net Margin %(computed) | — | — | — | -732.64% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.01 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 99.00M | 96.45M | 96.43M | 91.32M | 96.00M |
| EBITDA | ($0.12M) | $0.00M | $0.00M | $0.00M | $0.00M |
| EBITDA Margin %(computed) | — | 0.00% | 0.00% | 0.00% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Goldenwell Biotech, Inc.
关于Goldenwell Biotech, Inc.（GWLL）损益表
Goldenwell Biotech, Inc.（GWLL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，GWLL实现营收$0.00B，毛利润$0.00B（毛利率46.04%），净利润($0.00B)（净利率-94602.88%）。
常见问题
GWLL · 4 问Goldenwell Biotech, Inc.（GWLL）2024财年营收为$0.00B，同比down94.1%。
GWLL revenueGWLL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09